
















































































From fundamental research to industrial translation — WCAM 2027 invites original contributions across the full breadth of addiction medicine.
The fourth wave of the overdose crisis — driven by illicitly manufactured fentanyl, fentanyl analogs, and the veterinary sedative xylazine — has reshaped opioid use disorder care.
ExploreAlcohol use disorder remains the most prevalent substance use disorder yet the most undertreated, with fewer than ten percent of patients receiving evidence-based pharmacotherapy.
ExploreStimulant use disorder has surged alongside the opioid crisis, with methamphetamine and cocaine now frequently co-detected with fentanyl in overdose decedents.
ExploreBehavioral addictions occupy a contested but expanding diagnostic space, with gambling disorder formally classified in DSM-5-TR and ICD-11, internet gaming disorder under continued study, and compulsive sexual behavior disorder added to ICD-11.
ExploreHarm reduction has moved from the margins to the center of US addiction policy following the 2022 federal endorsement of syringe services and OTC naloxone (Narcan, RiVive) approval.
ExploreMedications for addiction treatment remain dramatically underutilized despite decades of evidence, with fewer than a quarter of patients with OUD receiving buprenorphine, methadone, or naltrexone.
ExploreWCAM 2027 is a global forum for pioneering research, clinical translation and cross-disciplinary dialogue across the full spectrum of addiction medicine and behavioral health.
Across two days of keynotes, parallel technical tracks, poster sessions and focused workshops, we convene clinicians, researchers and policy leaders to chart the frontier of recovery medicine.
WCAM 2027 is more than a conference — it is a launchpad for your research, your clinical practice, and your next translational collaboration.
Hear first on breakthrough findings across 35 scientific sessions in addiction medicine & behavioral health.
Keynote, plenary and invited speakers from leading US and international institutions.
Connect with researchers, clinicians and industry leaders across 12+ countries — in one room, over two days.
All accepted abstracts published in the ISBN-allocated proceedings; selected papers invited to partner journals.
Best Paper, Best Poster and Young Investigator awards with global visibility and certificates of excellence.
Two days of curated networking and a gala dinner — attend on-site in the USA or stream every session live, worldwide.
Early-bird pricing available until July 14, 2026. All fees include the full two-day program, conference kit, lunches and networking events.
Mark these deadlines to stay ahead of abstract submission, registration and arrival.
Everything you need to submit abstracts, prepare presentations, and share WCAM 2027 with your colleagues.